day after day we see nothing, why is this stock so hated.
By a 7-2 margin, the Supreme Court has ruled in favor of Teva Pharmaceuticals in its patent suit against generic drugmakers, thereby reversing a federal appeals court (CAFC) decision that declared a patent in dispute was invalid, and sending the case back for further review.Vringo (NASDAQ:VRNG) appears to have gotten a lift from the ruling. The company is a month removed from stating it will seek a Supreme Court review of the CAFC's adverse ruling against Vringo regarding its infringement suit against Google, after the CAFC denied a petition for an en banc review of its decision. (hat tip: Patent Plays)
tough markets those Chinese, very fickled...
just chilling and waiting.
like Mannkind, Kerx is taking the well thought out plan for continued success. These creative thinkers have done there jobs, create, drive and get approval, now it's time to run as a business, build sales force, educate, expansion. Enough said.
have done their jobs, now it's time for shifting from obtaining FDA approval, to launching drug, building a sales force, education and expansion. Legacy plan taking control. Perfect
expect this to get to 7 over next few days, shorts fighting hard to keep a lid on this...
the scramble has begun since yesterday, more to follow.
not sure but bad news will flush out all these day traders and short term players